Riskpilot← Back to searchSign inGet full accessCarolus AB
ABActiveOrg 5569006967Tenstagången 24General medical practice activities · NACE 8621Est. 20126 employees
Revenue 2025
SEK 9,3M
+12% vs 2024
EBITDA margin
3.0%
-25% vs 2024
Equity ratio
39.5%
Financial strength
Net profit 2025
SEK 101K
-40% vs 2024
| Revenue | SEK 9,3M | +12% |
| EBITDA | SEK 283K | -25% |
| Net profit | SEK 101K | -40% |
| Total assets | SEK 2,9M | -17% |
| Equity | SEK 1,2M | -30% |
| Employees | 6 | — |
Legal name
Carolus AB
Org number
5569006967
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
15 augusti 2012
Share capital
SEK 100 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Hälso- och sjukvård, primärvård samt företagshälsovård. Verksamheten omfattar även allmän medicin estetisk, dermatologi och kirurgi, marknadsföring och försäljning av medicinsk utrustning, medicinsk litteratur samt medicinska produkter, forskning, utveckling, anordnande av kurser, utbildningar och föreläsningar. Hyra ut vårdpersonal. Bolaget ska bedriva handel med värdepapper, ävensom äga, förvärva och förvalta fast och lös egendom, samt därmed förenlig verksamhet.
Address
Tenstagången 24
Email
karima.djoumi@halsan.eu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 6 569 | 7 807 | 7 730 | 7 494 | 7 952 | 13 069 | 8 318 | 9 342 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 464 | 559 | 931 | 461 | 810 | −166 | −98 | 16 | 377 | 283 |
| Depreciation & amort. | −31 | −31 | −43 | −70 | −53 | −53 | −53 | −140 | −80 | −158 |
| EBIT | 433 | 528 | 888 | 391 | 757 | −219 | −151 | −124 | 297 | 125 |
| Net financials | −37 | −28 | −15 | −8 | −12 | −10 | −1 | 389 | −9 | −6 |
| Profit before tax | 396 | 369 | 708 | 383 | 580 | 6 | 8 | 196 | 214 | 133 |
| Tax | −16 | −87 | −157 | −105 | −107 | −5 | −5 | −46 | −46 | −32 |
| Net profit | 380 | 282 | 551 | 278 | 473 | 1 | 3 | 150 | 168 | 101 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 833 | 1 171 | 2 368 | 2 494 | 3 002 | 2 708 | 2 343 | 3 501 | 3 543 | 2 936 |
| Equity | 124 | 405 | 956 | 1 234 | 1 706 | 1 708 | 1 711 | 1 861 | 1 659 | 1 160 |
| Long-term debt | 83 | 0 | 0 | 0 | 0 | 0 | 0 | 131 | 562 | 445 |
| Short-term debt | 626 | 635 | 1 117 | 965 | 836 | 775 | 567 | 1 374 | 1 113 | 1 137 |
| Total debt | 709 | 635 | 1 117 | 965 | 836 | 775 | 567 | 1 505 | 1 675 | 1 582 |
EBITDA margin
3.0%
This company
15.8%
Market median
-81% vs market
20152025
Equity ratio
39.5%
This company
38.2%
Market median
+3% vs market
20152025
Return on equity
8.7%
This company
18.4%
Market median
-53% vs market
20152025
Net profit margin
1.1%
This company
8.1%
Market median
-86% vs market
20152025
Asset turnover
3.18×
This company
1.12×
Market median
+184% vs market
20152025
Debt / equity
1.53×
This company
0.62×
Market median
-147% vs market
20152025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-01-01 – 2023-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MF Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Carolus Holding AB | Company | 51.0% | 51.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Carolus Holding AB
Carolus AB Board members of Carolus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magnus Fredrik Hamberg | Chief Auditor | 0 companies |
| Mohamed Yacine Djoumi | Deputy Board Member | 0 companies |
| Salah Eddine Djoumi | Board of Directors | 0 companies |
| Yasmine Djoumi | Deputy Board Member | 0 companies |
| Karima Djoumi | Chairman | 0 companies |